Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

79.00
EUR
-1.50
(-1.86%)
-3.46EPS
4.28BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q1 FY2021 · Quarterly report

May 6, 2021 · 96 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q1 FY2021 documents